Cargando…
Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New Perspectives
Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system, with poor survival in both treated and untreated patients. Recent studies began to explain the molecular pathway, comprising the dynamic structural and mechanical changes involved in GBM. In this cont...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479730/ https://www.ncbi.nlm.nih.gov/pubmed/30978987 http://dx.doi.org/10.3390/ijms20071796 |